Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV

The integrase inhibitor dolutegravir was included in initial antiretroviral therapy in Brazil in January 2017. Studies have demonstrated that the efficacy and safety of antiretrovirals have improved with the introduction of new classes of antiretrovirals, such as integrase inhibitors. This study aim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Correa, Analú, Monteiro, Polyana, Calixto, Fernanda, Batista, Joanna d’Arc Lyra, de Alencar Ximenes, Ricardo Arraes, Montarroyos, Ulisses Ramos
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7458288/
https://ncbi.nlm.nih.gov/pubmed/32866163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0238052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados